Sign up to save your podcasts
Or
Share Biotech Bros
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biotech Bros
Biotech Bros episodes
- Aggressive Management for $LPTX and Fraud in Alzheimer's and $SAVA
This week on the podcast Agustin discusses Leap Therapeutics and their R&D day as well as the news that Novartis is discontinuing their PD-L1 submission for NSCLC and finally he sheds light on a scandal that is rocking neuroscience research and Alzheimer's drug development.
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
1 hr 3 min - Acquisitions in the $XBI, a Second Chance at bat for $AMLX, and a Potential Cure for Huntington's
This week on the podcast Agustin discusses the recent acquisition activity in the biotech space, some positive news for Amylyx Pharmaceuticals regarding a new chance to convince regulators of an approval at their second ad-board, and an incredible data readout for a new gene therapy targeting Huntington's Disease.
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
58 min - More Issues for CRISPR Therapeutics: Another CAR-T Failure in Solid Tumors
This week on the podcast Agustin discusses the recent data release from CRISPR Therapeutics, Galapagos' CAR-T cell therapy acquisition, and the over-saturation of SCD therapies entering the market.
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
46 min - How to Navigate Biotech with Maxim Jacobs
This week on the podcast Agustin sits down with Maxim Jacobs. Maxim is a senior vice president at Russo Partners and has multiple years of experience in biotech investing. On this episode, Agustin and Maxim discuss the recent biotech market fluctuations and sell-off as well as some practical advice for retail investors looking to enter the space.
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
57 min - Major Win for GSK and Uncertainty for Infinity Pharmaceuticals
On this week's episode, Agustin discusses the recent data release of Jemperli and how it may be a viable solution for dMMR solid tumor patients. He also provides updates on Amylyx Pharmaceuticals and their recent approval in Canada, Leap Therapeutics and their prostate cancer readout, and Infinity Pharmaceuticals and their risky jam-packed future.
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
1 hr 7 min - The Failure of TIGIT Antibodies and the battle for KRAS Superiority
On this week's episode, Agustin discusses the failures of targeting TIGIT antibodies, the competitive race for KRAS superiority, and the pitfalls of Caribou Biosciences and their allogeneic CAR-T cell therapy.
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
39 min - Sneak Peak into ASCO and Conflicting $PDSB Data
On this week's episode, Agustin shares some preliminary insights from ASCO and dives into both the lack of data from $AFMD and the less than spectacular update from $PDSB. Additionally, yet another biotech company has been acquired and this one is a late stage commercial company! Is there hope for $XBI after all?
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
41 min - The Future of TechBio: One on One with Jeff Galvin of American Gene Technologies
This week on the podcast Agustin sits down with Jeff Galvin, the CEO and founder of American Gene Technologies, an innovative cell therapy company looking to build the infrastructure necessary to spur innovation in gene and cell therapy development. Much like Microsoft and Apple transformed the tech world, AGT is looking to establish the future of what Jeff calls "TechBio".
All Business. No Boundaries.
To learn more about American Gene Technologies, check them out https://www.americangene.com/
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
1 hr 1 min - One on One Interview with BioMark Diagnostics CEO
This week on the podcast Agustin sits down with Rashid Bux, the CEO and founder of BioMark Diagnostics, an early stage innovative diagnostic startup developing a ground breaking metabolomics and biomarker detection platform for oncology.
To learn more about BioMark Diagnostics, check them out at https://www.biomarkdiagnostics.com/
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
All Business. No Boundaries.
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
48 min - The Winners and Losers of AACR
On this week's episode, Agustin highlights the winners and losers of this years AACR conference and discusses how $TGTX went from being a promising biotech investment to a company with limited options and commercial hopes.
All Business. No Boundaries.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
51 min
About Biotech Bros
From the publisher's feed
Discussing the world of biotech!